Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus

A 61‐year‐old male on everolimus had chronic SARS‐CoV‐2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID‐19.

Detalles Bibliográficos
Autores principales: Frankel, Arthur E., Yip, Wai C., Naik, Eknath, Hasselbalch, Hans C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190516/
https://www.ncbi.nlm.nih.gov/pubmed/34136234
http://dx.doi.org/10.1002/ccr3.4218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190516/
https://www.ncbi.nlm.nih.gov/pubmed/34136234
http://dx.doi.org/10.1002/ccr3.4218

Ejemplares similares